A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
SC-74020
Esketamine
The serum concentration of Ubrogepant can be decreased when it is combined with Esketamine.
SC-74020
Lesinurad
The serum concentration of Ubrogepant can be decreased when it is combined with Lesinurad.
SC-74020
Eslicarbazepine acetate
The serum concentration of Ubrogepant can be decreased when it is combined with Eslicarbazepine acetate.
SC-74020
Glycerol phenylbutyrate
The serum concentration of Ubrogepant can be decreased when it is combined with Glycerol phenylbutyrate.
SC-74020
Armodafinil
The serum concentration of Ubrogepant can be decreased when it is combined with Armodafinil.
SC-74020
Tocilizumab
The serum concentration of Ubrogepant can be decreased when it is combined with Tocilizumab.
SC-74020
Rufinamide
The serum concentration of Ubrogepant can be decreased when it is combined with Rufinamide.
SC-74020
Oritavancin
The serum concentration of Ubrogepant can be decreased when it is combined with Oritavancin.
SC-74020
Echinacea
The serum concentration of Ubrogepant can be decreased when it is combined with Echinacea.
SC-74020
Avasimibe
The serum concentration of Ubrogepant can be decreased when it is combined with Avasimibe.
SC-74020
Piperaquine
The serum concentration of Ubrogepant can be increased when it is combined with Piperaquine.
SC-74020
Sarilumab
The serum concentration of Ubrogepant can be increased when it is combined with Sarilumab.
SC-74020
Acalabrutinib
The serum concentration of Ubrogepant can be increased when it is combined with Acalabrutinib.
SC-74020
Manidipine
The serum concentration of Ubrogepant can be increased when it is combined with Manidipine.
SC-74020
Siltuximab
The serum concentration of Ubrogepant can be increased when it is combined with Siltuximab.
SC-74020
Lanreotide
The serum concentration of Ubrogepant can be increased when it is combined with Lanreotide.
SC-74020
Fosaprepitant
The serum concentration of Ubrogepant can be increased when it is combined with Fosaprepitant.
SC-74020
Pasireotide
The serum concentration of Ubrogepant can be increased when it is combined with Pasireotide.
SC-74020
Clevidipine
The serum concentration of Ubrogepant can be increased when it is combined with Clevidipine.
SC-74020
Vapreotide
The serum concentration of Ubrogepant can be increased when it is combined with Vapreotide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3